Skip to main content
. 2021 Jun 25;21:127. doi: 10.1186/s12902-021-00798-3

Fig. 4.

Fig. 4

Correlation between the ratio (2011 compared to 2007) of intensity of prescribing policy for all antidiabetic medicines and volume market share of incretin-based medicines (DDP-4 inhibitors and GLP-1 receptor agonists) in 2011